Skip to content
★ Sign in to follow
LE

Lars Ekman

Board Director
Director
Ultragenyx Pharmaceutical Inc.Prothena CORP Public Ltd CoAmarin CORP Plc\ukSpark Therapeutics, Inc.Intermune IncSophiris Bio Inc.
Total declarations
64
Companies
6
▲ Purchases (1 ops.)
€53k
▼ Sales (32 ops.)
€14.1M

Latest filing published 05 Jan 2023 for Prothena CORP Public Ltd Co, €173k.

Filing timeline

BuySale
Lars Ekman

Insider track record

Disclosed buys
1
Disclosed sells
32
Signal history

Closed purchases

Market purchases
1

Not enough history yet: 1 closed purchase, at least 2 are needed.

Purchases by company

Since each purchase

  • Filed 20 Nov 2013 · 4736 days ago · €53k
    -27.8%
    Entry US$35.20 · Close at T+365 US$25.40

Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.

Lars Ekman: trading record in brief

Lars Ekman is a declared insider at 6 companies (board member); the most frequent names are Prothena CORP Public Ltd Co, Amarin CORP Plc\uk and Ultragenyx Pharmaceutical Inc. In total, 64 filings cover trades dated from 4 June 2012 to 3 January 2023.

The open-market side counts 1 purchase for €53k alongside 32 sales for €14.1M. Taken together, the sales exceed the purchases by €14.0M. Unlike grants, an open-market purchase is paid for by the insider, at the market price. Outside the open market, there are 8 share grants and 21 option exercises. In 2023 alone, the filings show no purchases and 7 sales.

The latest filing, published on 5 January 2023, reports an open-market sale of €173k in Prothena CORP Public Ltd Co. The clock since the last published purchase (20 November 2013) now reads 4,736 days. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. Section 16 rules allow two business days to file each Form 4. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.

Companies and markets linked to Lars Ekman

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations63 total
  • ▼
    DirectorExecutivesProthena CORP Public Ltd Co
    184,706 USD29SEC
    3,411 shares@ US$54.152.9% of flowOrdinary Shares, par value $0.01 per shareSEC:0001567619-23-000574:1
  • ▼
    DirectorExecutivesProthena CORP Public Ltd Co
    160,349 USD29SEC
    2,897 shares@ US$55.352.5% of flowOrdinary Shares, par value $0.01 per shareSEC:0001567619-23-000574:2
  • ▼
    DirectorExecutivesProthena CORP Public Ltd Co
    372,961 USD30SEC
    6,621 shares@ US$56.335.9% of flowOrdinary Shares, par value $0.01 per shareSEC:0001567619-23-000574:3
  • ▼
    DirectorExecutivesProthena CORP Public Ltd Co
    74,245 USD29SEC
    1,303 shares@ US$56.981.2% of flowOrdinary Shares, par value $0.01 per shareSEC:0001567619-23-000574:4
  • ▼
    DirectorExecutivesProthena CORP Public Ltd Co
    89,354 USD29SEC
    1,523 shares@ US$58.671.4% of flowOrdinary Shares, par value $0.01 per shareSEC:0001567619-23-000574:5
  • ▼
    DirectorExecutivesProthena CORP Public Ltd Co
    595 USD29SEC
    10 shares@ US$59.460.0% of flowOrdinary Shares, par value $0.01 per shareSEC:0001567619-23-000574:6
  • ▼
    DirectorExecutivesProthena CORP Public Ltd Co
    4,199 USD29SEC
    69 shares@ US$60.850.1% of flowOrdinary Shares, par value $0.01 per shareSEC:0001567619-23-000574:7
  • ◇
    DirectorExecutivesProthena CORP Public Ltd Co
    101,496 USD13SEC
    15,834 shares@ US$6.4115.7% of flowOrdinary Shares, par value $0.01 per shareSEC:0001567619-23-000574:0
  • ▼
    DirectorExecutivesProthena CORP Public Ltd Co
    601,341 USD30SEC
    9,813 shares@ US$61.289.7% of flowOrdinary Shares, par value $0.01 per shareSEC:0001140361-22-044319:1
  • ▼
    DirectorExecutivesProthena CORP Public Ltd Co
    374,025 USD30SEC
    6,021 shares@ US$62.126.0% of flowOrdinary Shares, par value $0.01 per shareSEC:0001140361-22-044319:2
  • ◇
    DirectorExecutivesProthena CORP Public Ltd Co
    101,496 USD13SEC
    15,834 shares@ US$6.4116.0% of flowOrdinary Shares, par value $0.01 per shareSEC:0001140361-22-044319:0
  • ▼
    DirectorExecutivesProthena CORP Public Ltd Co
    566,957 USD30SEC
    9,143 shares@ US$62.019.7% of flowOrdinary Shares, par value $0.01 per shareSEC:0001140361-22-039911:1
  • ▼
    DirectorExecutivesProthena CORP Public Ltd Co
    108,016 USD29SEC
    1,717 shares@ US$62.911.8% of flowOrdinary Shares, par value $0.01 per shareSEC:0001140361-22-039911:2
  • ▼
    DirectorExecutivesProthena CORP Public Ltd Co
    212,829 USD29SEC
    3,312 shares@ US$64.263.6% of flowOrdinary Shares, par value $0.01 per shareSEC:0001140361-22-039911:3
  • ▼
    DirectorExecutivesProthena CORP Public Ltd Co
    107,865 USD29SEC
    1,661 shares@ US$64.941.8% of flowOrdinary Shares, par value $0.01 per shareSEC:0001140361-22-039911:4
  • ◇
    DirectorExecutivesProthena CORP Public Ltd Co
    101,490 USD13SEC
    15,833 shares@ US$6.4116.9% of flowOrdinary Shares, par value $0.01 per shareSEC:0001140361-22-039911:0
  • ▼
    DirectorExecutivesProthena CORP Public Ltd Co
    211,603 USD29SEC
    3,508 shares@ US$60.323.6% of flowOrdinary Shares, par value $0.01 per shareSEC:0001567619-22-018291:1
  • ▼
    DirectorExecutivesProthena CORP Public Ltd Co
    261,196 USD29SEC
    4,277 shares@ US$61.074.5% of flowOrdinary Shares, par value $0.01 per shareSEC:0001567619-22-018291:2
  • ▼
    DirectorExecutivesProthena CORP Public Ltd Co
    394,709 USD30SEC
    6,355 shares@ US$62.116.8% of flowOrdinary Shares, par value $0.01 per shareSEC:0001567619-22-018291:3
  • ▼
    DirectorExecutivesProthena CORP Public Ltd Co
    106,591 USD29SEC
    1,693 shares@ US$62.961.8% of flowOrdinary Shares, par value $0.01 per shareSEC:0001567619-22-018291:4
  • ◇
    DirectorExecutivesProthena CORP Public Ltd Co
    101,490 USD13SEC
    15,833 shares@ US$6.4117.0% of flowOrdinary Shares, par value $0.01 per shareSEC:0001567619-22-018291:0
  • ▼
    DirectorExecutivesProthena CORP Public Ltd Co
    2M USD32SEC
    31,666 shares@ US$48.0926.4% of flowOrdinary Shares, par value $0.01 per shareSEC:0001140361-22-035561:1
  • ◇
    DirectorExecutivesProthena CORP Public Ltd Co
    202,979 USD14SEC
    31,666 shares@ US$6.4134.4% of flowOrdinary Shares, par value $0.01 per shareSEC:0001140361-22-035561:0
  • ◆
    DirectorExecutivesUltragenyx Pharmaceutical Inc.
    0SEC
    3,300 shares0Common StockSEC:0001209191-22-039567:0
  • ◆
    DirectorExecutivesUltragenyx Pharmaceutical Inc.
    0SEC
    2,145 shares0Common StockSEC:0001209191-21-043543:0

25 of 63 declarations